Extended Pembrolizumab Duration Tied to Lower Mortality in Stage III and IV Melanoma: JDD Report Could extending pembrolizumab improve survival? This JDD is a must read. A new retrospective analysis…
Read More
Metformin and Skin Cancer: Emerging Evidence for Dermatologic Oncology If you are curious about metabolic agents in dermatologic oncology this JDD article is a must read. A new review synthesizes…
Read More
From the Vault: A JDD survey of dermatology residents highlights concerns among underrepresented groups that may influence interest in Mohs micrographic surgery and dermatologic oncology fellowships In this article from…
Read More
Combined Relabotulinum Toxin A frontalis modulation with NASHA™ gel skinboosters for the temples yields natural‑looking wrinkle softening and lasting skin quality gains beyond six months The Oncoderm Resource Center on…
Read More
Dermatology On-Call Data Uncover Trends in Hematology–Oncology Cutaneous Complications Oncodermatology consults for hematological malignancy patients often uncover therapy-related skin toxicities that can derail cancer treatment. In a retrospective review of…
Read More
Did You Miss These? Must-Listen JDD Podcasts on Acne, Dyspigmentation & Oncodermatology! Dermatology is always evolving, and if you haven’t caught the latest 'Ask the Investigator' podcast episodes, you’re missing…
Read More
Spotlight on Rosacea: Beyond the Redness This National Rosacea Month April marks National Rosacea Month, a timely reminder for dermatology professionals to sharpen their diagnostic lens beyond textbook erythema. While…
Read More
Listen Now! Dermatology is always evolving, and if you haven’t caught the latest "Ask the Investigator" podcast episodes, you're missing out on game-changing insights! Hosted by the always-engaging Dr. Adam…
Read More
Prioritizing Skincare in Cancer Treatment: A Latin American Initiative Cancer treatments often lead to skin-related side effects that impact quality of life and, in some cases, treatment adherence. The Latin…
Read More
